In a phase 3 randomized trial, investigators evaluated whether finerenone added to the background renin–angiotensin system blockade, thereby reducing albuminuria in adults with type 1 diabetes and chronic...
A phase 3 trial evaluates whether first-line disitamab vedotin combined with toripalimab could improve outcomes compared with platinum-based chemotherapy in patients with previously untreated...
On November 10, the U.S. Department of Health and Human Services announced that the FDA is initiating the removal of certain black box warnings from hormone replacement therapy products for menopause,...
In a large real-world cohort study comparing semaglutide with metformin, investigators found no significant difference in the risk of incident urinary stone disease. Despite meaningful reductions in BMI...
A multicenter randomized trial has demonstrated that the NeuroSAFE technique significantly improves erectile function and accelerates early urinary continence recovery following robot-assisted radical...
The FDA announced the approval of darolutamide for treating metastatic castration-sensitive prostate cancer. This review was conducted under Project Orbis, which allows for concurrent submission and review...
A presentation at the Practical Updates in Primary Care 2025 virtual conference explored three cases, challenging primary care providers to rethink common infectious disease diagnoses while emphasizing the...
Researchers set out to determine whether short-course vaginal cuff brachytherapy regimen maintains quality of life and acceptable toxicity in patients with early-stage endometrial cancer.
An ultra-low-dose 0.005% estriol vaginal gel reduced recurrent urinary tract infections in postmenopausal women with genitourinary syndrome of menopause, offering a safe and effective alternative to...
